X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (226) 226
Book Review (20) 20
Conference Proceeding (20) 20
Publication (12) 12
Book / eBook (3) 3
Dissertation (3) 3
Patent (3) 3
Book Chapter (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (143) 143
humans (136) 136
male (83) 83
female (81) 81
gastroenterology & hepatology (76) 76
middle aged (66) 66
adult (64) 64
abridged index medicus (43) 43
helicobacter pylori (36) 36
aged (35) 35
helicobacter infections - complications (18) 18
adolescent (17) 17
helicobacter infections - drug therapy (17) 17
aged, 80 and over (15) 15
duodenal-ulcer (15) 15
oncology (15) 15
stomach neoplasms - pathology (15) 15
apoptosis (14) 14
duodenal ulcer - drug therapy (14) 14
nonsteroidal antiinflammatory drugs (14) 14
recurrence (14) 14
risk factors (13) 13
animals (12) 12
anti-ulcer agents - therapeutic use (12) 12
duodenal ulcer (12) 12
infection (12) 12
prospective studies (12) 12
expression (11) 11
gastric cancer (11) 11
hong kong (11) 11
medicine, general & internal (11) 11
prevalence (11) 11
proton pump inhibitors (11) 11
anti-bacterial agents - therapeutic use (10) 10
carcinoma (10) 10
diagnosis (10) 10
health aspects (10) 10
helicobacter pylori - isolation & purification (10) 10
incidence (10) 10
risk (10) 10
tumor cells, cultured (10) 10
apoptosis - drug effects (9) 9
aspirin (9) 9
duodenal ulcer - complications (9) 9
helicobacter infections - microbiology (9) 9
rats (9) 9
cancer (8) 8
clinical trials as topic (8) 8
colorectal-cancer (8) 8
endoscopy (8) 8
eradication (8) 8
helicobacter infections - diagnosis (8) 8
management (8) 8
omeprazole - therapeutic use (8) 8
peptic ulcer (8) 8
prevention (8) 8
research (8) 8
surveys and questionnaires (8) 8
treatment outcome (8) 8
up-regulation (8) 8
asian continental ancestry group (7) 7
blotting, western (7) 7
case-control studies (7) 7
china (7) 7
chronic disease (7) 7
disease (7) 7
drug therapy, combination (7) 7
gastric acid - secretion (7) 7
gastric mucosa - pathology (7) 7
gastrins - blood (7) 7
gastritis (7) 7
helicobacter infections - pathology (7) 7
helicobacter-pylori (7) 7
helicobacter-pylori infection (7) 7
prognosis (7) 7
rats, sprague-dawley (7) 7
stomach cancer (7) 7
stomach neoplasms - enzymology (7) 7
stomach neoplasms - etiology (7) 7
time factors (7) 7
age factors (6) 6
anti-inflammatory agents, non-steroidal - pharmacology (6) 6
association (6) 6
biochemistry & molecular biology (6) 6
cell division - drug effects (6) 6
child (6) 6
cyclooxygenase inhibitors - pharmacology (6) 6
dose-response relationship, drug (6) 6
double-blind method (6) 6
drug therapy (6) 6
gastric juice - secretion (6) 6
gastritis - microbiology (6) 6
hong kong - epidemiology (6) 6
infections (6) 6
inflammation (6) 6
sensitivity and specificity (6) 6
smoking (6) 6
stomach neoplasms - metabolism (6) 6
stomach neoplasms - prevention & control (6) 6
sulfonamides - pharmacology (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1997, ISBN 9789622094314, xviii, 207
Book
Journal of Gastroenterology and Hepatology (Australia), ISSN 0815-9319, 2009, Volume 24, Issue 10, pp. 1587 - 1600
The Asia-Pacific Consensus Conference was convened to review and synthesize the most current information on Helicobacter pylori management so as to update the... 
Helicobacter pylori:treatment and antimicrobial resistance | H. pylori and gastric cancer | Helicobacter pylori:diagnosis | C-13-UREA BREATH TEST | helicobacter pylori:diagnosis | helicobacter pylori:treatment and antimicrobial resistance | RIFABUTIN TRIPLE THERAPY | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | GASTROESOPHAGEAL-REFLUX DISEASE | VS. QUADRUPLE THERAPY | 2ND-LINE TREATMENT | ERADICATION THERAPY | DUODENAL-ULCER PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | PEPTIC-ULCER | Predictive Value of Tests | Helicobacter Infections - ethnology | Humans | Breath Tests | Drug Resistance, Bacterial | Helicobacter Infections - complications | Treatment Outcome | Evidence-Based Medicine | Proton Pump Inhibitors - therapeutic use | Helicobacter Infections - therapy | Anti-Bacterial Agents - therapeutic use | Asia - epidemiology | Asian Continental Ancestry Group | Helicobacter pylori - isolation & purification | Microbiological Techniques | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Helicobacter Infections - microbiology | Gastroesophageal reflux | Medical colleges | Drug resistance in microorganisms | Aspirin | Care and treatment | Anemia | Antidiarrheals | Cytochrome P-450 | Practice guidelines (Medicine) | Peptic ulcer | Antiulcer drugs | Prevention | Helicobacter pylori | Amoxicillin | Lymphomas | Health aspects | Smoking | Cancer | Index Medicus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2006, Volume 193, Issue 7, pp. 1037 - 1046
Background. Cyclooxygenases (COXs) play important roles in inflammation and carcinogenesis. The present study aimed to determine the effects of COX-1 and COX-2... 
Cell growth | Messenger RNA | Helicobacter pylori | Cytokines | Epithelial cells | Cyclooxygenase inhibitors | Bacteria | Infections | Inflammation | Apoptosis | Gastritis | EPITHELIAL-CELL PROLIFERATION | INFECTIOUS DISEASES | CANCER CELLS | INDUCED APOPTOSIS | NITRIC-OXIDE SYNTHASE | MICROBIOLOGY | IMMUNOLOGY | NATURAL-HISTORY | INHIBITOR SC-236 | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | INFECTION | MONGOLIAN GERBILS | PROSTAGLANDIN SYNTHESIS | Dinoprostone - analysis | Gastric Mucosa - microbiology | Cell Proliferation | Tumor Necrosis Factor-alpha - genetics | Helicobacter pylori - pathogenicity | RNA, Messenger - analysis | Gastric Mucosa - pathology | Helicobacter Infections - pathology | Cyclooxygenase 2 - genetics | Gastritis - pathology | Leukotriene C4 - analysis | Gastritis - microbiology | Leukotriene B4 - analysis | Disease Models, Animal | Cyclooxygenase 1 - genetics | Enzyme-Linked Immunosorbent Assay | Mice, Inbred C57BL | Gene Expression Regulation | Cyclooxygenase 1 - physiology | Cyclooxygenase 2 - physiology | Helicobacter Infections - immunology | Mice, Knockout | Gastric Mucosa - immunology | Helicobacter Infections - enzymology | Animals | Cyclooxygenase 1 - deficiency | Gastritis - immunology | Interleukin-10 - genetics | Gastritis - enzymology | Mice | Cyclooxygenase 2 - deficiency | Helicobacter Infections - microbiology | Cyclooxygenases | Control | Health aspects | Prostanoids | Index Medicus | Abridged Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 01/2004, Volume 291, Issue 2, pp. 187 - 194
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2002, Volume 346, Issue 26, pp. 2033 - 2038
Journal Article
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 03/2008, Volume 23, Issue 3, pp. 351 - 365
Background and Aim:  Gastric cancer is a major health burden in the Asia–Pacific region but consensus on prevention strategies has been lacking. We aimed to... 
guidelines | gastric cancer | Helicobacter pylori | prevention | Prevention | Gastric cancer | Guidelines | 10-YEAR FOLLOW-UP | DUODENAL-ULCER DISEASE | RANDOMIZED CONTROLLED-TRIAL | NESTED CASE-CONTROL | GENE POLYMORPHISMS | HELICOBACTER-PYLORI INFECTION | GASTROESOPHAGEAL-REFLUX DISEASE | INCREASED RISK | GASTROENTEROLOGY & HEPATOLOGY | PEPTIC-ULCER | SERUM PEPSINOGEN-I | Prevalence | Vegetables | Adenocarcinoma - etiology | Humans | Helicobacter pylori - genetics | Helicobacter Infections - complications | Mass Screening - methods | Incidence | Anti-Bacterial Agents - therapeutic use | Pacific Islands - epidemiology | Ascorbic Acid - therapeutic use | Helicobacter Infections - drug therapy | Pepsinogens - analysis | Stomach Neoplasms - epidemiology | Helicobacter Infections - diagnosis | Stomach Neoplasms - etiology | Anticarcinogenic Agents - therapeutic use | Genetic Predisposition to Disease | Stomach Neoplasms - diagnosis | Fruit | Risk Assessment | Biomarkers, Tumor - analysis | Risk Factors | Sodium Chloride, Dietary - adverse effects | Helicobacter Infections - epidemiology | Evidence-Based Medicine | Vitamins - therapeutic use | Adenocarcinoma - diagnosis | Asia - epidemiology | Adenocarcinoma - prevention & control | Pedigree | Stomach Neoplasms - prevention & control | Adenocarcinoma - epidemiology | Dietary Supplements | Helicobacter Infections - microbiology | Helicobacter Infections, drug therapy | Stomach Neoplasms, prevention and control | Sodium Chloride, Dietary, adverse effects | Helicobacter Infections, microbiology | Anticarcinogenic Agents, therapeutic use | Asia, epidemiology | Helicobacter Infections, epidemiology | Mass Screening, methods | Pepsinogens, analysis | Helicobacter pylori, genetics | Stomach Neoplasms, epidemiology | Tumor Markers, Biological, analysis | Stomach Neoplasms, etiology | Ascorbic Acid, therapeutic use | Adenocarcinoma, prevention and control | Adenocarcinoma, diagnosis | Pacific Islands, epidemiology | Adenocarcinoma, epidemiology | Helicobacter Infections, complications | Mass Screening | Stomach Neoplasms, diagnosis | Adenocarcinoma, etiology | Vitamins, therapeutic use | Anti-Bacterial Agents, therapeutic use | Helicobacter Infections, diagnosis | Practice guidelines (Medicine) | Stomach cancer | Cancer | Index Medicus
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 2005, Volume 118, Issue 11, pp. 1271 - 1278
Selective cyclooxygenase-2 (COX-2) inhibitors cause significantly fewer peptic ulcers than conventional nonselective nonsteroidal anti-inflammatory drugs... 
Celecoxib | NSAIDs | Ulcers | Lansoprazole | RHEUMATOID-ARTHRITIS | lansoprazole | celecoxib | CARDIOVASCULAR EVENTS | OMEPRAZOLE | RISK | TRIAL | MEDICINE, GENERAL & INTERNAL | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | DOUBLE-BLIND | ROFECOXIB | ulcers | HELICOBACTER-PYLORI | Recurrence | Pyrazoles - therapeutic use | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Peptic Ulcer - prevention & control | Male | Dyspepsia - chemically induced | Peptic Ulcer - epidemiology | Incidence | Cyclooxygenase 2 Inhibitors - adverse effects | Helicobacter pylori | Helicobacter Infections - drug therapy | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Adult | Female | Drug Therapy, Combination | Pyrazoles - adverse effects | Naproxen - adverse effects | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Proton Pump Inhibitors | Omeprazole - administration & dosage | Risk Factors | Peptic Ulcer Hemorrhage - chemically induced | Treatment Outcome | Naproxen - therapeutic use | Anti-Ulcer Agents - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Sulfonamides - adverse effects | 2-Pyridinylmethylsulfinylbenzimidazoles | Aged | Peptic Ulcer - chemically induced | Omeprazole - analogs & derivatives | Peptic ulcer | Complications and side effects | Dosage and administration | Drug therapy | Inhibitor drugs | Comparative analysis | Digestive system | Index Medicus | Abridged Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 11/2001, Volume 20, Issue 55, pp. 8009 - 8018
Triptolide, a major component in the extract of Chinese herbal plant Tripterygium wilfordii Hook f (TWHf), has potential anti-neoplastic effect. In the present... 
NF-κB | p53 status | AP-1 | Gastric cancer | Apoptosis | WILD-TYPE P53 | TRANSFORMATION | TRIPTERYGIUM-WILFORDII | gastric cancer | PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | apoptosis | NECROSIS-FACTOR-ALPHA | INDUCTION | CELL BIOLOGY | GAMMA-IRRADIATION | ARREST | NF-kappa B | GENE | ONCOLOGY | GENETICS & HEREDITY | gastric carcinoma | triptolide
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 01/2004, Volume 291, Issue 2, p. 187
Wong et al seek to determine whether treatment of Helicobacter pylori infection reduces the incidence of gastric cancer. They found that the incidence of... 
Carcinogens | Infections | Drug therapy | Cancer
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 12/2002, Volume 17, Issue 4, pp. S510 - S510
Journal Article
Best Practice & Research Clinical Gastroenterology, ISSN 1521-6918, 02/2000, Volume 14, Issue 1, pp. 41 - 52
In general, peptic ulcer occurs at equal rates in the East and the West bur with marked regional differences in both, even within the same country. In the... 
UNITED-STATES | DUODENAL-ULCER | NORTH<